BIO-PATH HOLDINGS INC
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
BPTH$0.21-66.8%Stored close · as of Feb 18, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (Unaudited)
(In thousands, except par value)
| | | | | | | |
|---|---|---|---|---|---|---|
| · As of September 30, · As of December 31, | ||||||
| · · 2024 · · 2023 | ||||||
| | | | (unaudited) | | | |
| Assets · · | ||||||
| · · | ||||||
| Current assets · · | ||||||
| Cash | | $562 | | $1,052 | ||
| Prepaid drug product | | 531 | | 632 | ||
| Other current assets | | 1,806 | | 1,358 | ||
| Total current assets | | 2,899 | | 3,042 | ||
| | | | ||||
| Fixed assets | | | ||||
| Furniture, fixtures & equipment | | 1,120 | | 1,120 | ||
| Less accumulated depreciation | | (1,078) | | (1,044) | ||
| | | 42 | | 76 | ||
| | | | ||||
| Right of use operating assets | | 24 | | 102 | ||
| | | | | |||
| Total Assets | | $2,965 | | $3,220 | ||
| Liabilities & Shareholders' (Deficit) Equity | | | ||||
| Current liabilities | | | ||||
| Accounts payable | | $1,036 | | $457 | ||
| Accrued expenses | | 2,313 | | 1,346 | ||
| Current portion of lease liabilities | | 26 | | 103 | ||
| Total current liabilities | | 3,375 | | 1,906 | ||
| | | | | | ||
| Warrant liability | | 302 | | 863 | ||
| | | | | | | |
| Noncurrent lease liabilities | | — | | 10 | ||
| | | | | | | |
| Total Liabilities | | 3,677 | | 2,779 | ||
| | | | | | | |
| Shareholders' (deficit) equity | | | ||||
| Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding | | — | | — | ||
| Common stock, $.001 par value; 200,000 shares authorized; 3,710 and 618 shares issued and outstanding, respectively | | 4 | | 1 | ||
| Additional paid in capital | | 114,032 | | 108,047 | ||
| Accumulated deficit | | (114,748) | | (107,607) | ||
| Total shareholders' (deficit) equity | | (712) | | 441 | ||
| Total Liabilities & Shareholders' (Deficit) Equity | | $2,965 | | $3,220 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.